Extracellular Matrix in Renal Development and Cancer

Presented at: Cell Biology 2020
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Senior Postdoctoral Research Fellow, GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics in Urology, Children's Hospital Los Angeles
    BIOGRAPHY

Abstract

The extracellular matrix (ECM) is a three-dimensional structure that provides physical support for tissues/organs and biochemical/biomechanical cues for tissue morphogenesis, differentiation, and homeostasis. The continual remodeling (degradation/new synthesis) of the ECM is crucial for tissue homeostasis, development, and injury processes and contributes/regulates tumor malignancy, growth, and patient response to cancer treatment. Recent evidence shows that Wilms’ tumor (WT), pediatric cancer that accounts for 95% of the renal malignancies in children, could be considered an aberrant nephrogenesis, where nephron progenitors (NP) expressing SIX2 and CITED1  proliferate uncontrollably, hampering terminal differentiation into functional mature nephron structures. We have characterized via transcriptomic analysis and immunohistochemistry the composition of the ECM within the WT-NP and determine its role in cancer development, and identified how modulation of ECM proteins and their receptors in the NP niche might favor self-renewal vs. differentiation. We show that by altering the NP niche, we could promote NP self-renewal maintenance and hampered differentiation. Our data suggest that ECM secreted by cancerous NP promotes tumor development and growth, thus targeting ECM remodeling processes might be essential for the development of innovative treatment specifically designed to halt WT progression, particularly in patients with severe prognosis or recurrences.

Learning Objectives:

1. Identify the ECM composition in Wilms’ tumor

2. Identify how variation in the Wilms’ tumor nephron progenitor niche may promote continuous self-renewal and hamper differentiation


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
Loading Comments...
Show Resources